Author Correction: Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan

Affiliations

¹ Medical Affairs & Pharmacovigilance, Bayer Yakuhin Ltd, 2-4-9 Umeda, Kita-Ku, Osaka, Breeze Tower, 530-0001, Japan. suguru.okami@bayer.com.
² Aetion Inc, 5 Penn Plaza, New York, USA.
³ Medical Affairs & Pharmacovigilance, Bayer Yakuhin Ltd, 2-4-9 Umeda, Kita-Ku, Osaka, Breeze Tower, 530-0001, Japan.
⁴ Market Access & Public Affairs, Bayer Yakuhin, Ltd, 2-4-9 Umeda, Kita-Ku, Osaka, Japan.
⁵ Integrated Evidence Generation & Business Innovation, Bayer AG, 13342, Berlin, Germany.
⁶ Integrated Evidence Generation & Business Innovation, Bayer AG, 42096, Wuppertal, Germany.
⁷ Integrated Evidence Generation & Business Innovation, Bayer Consumer Care AG, Peter Merian Straße 84, 4052, Basel, Switzerland.

Published Erratum

Suguru Okami et al. Sci Rep. 2024.

. 2024 Oct 15;14(1):24193.

doi: 10.1038/s41598-024-75133-6.

¹ Medical Affairs & Pharmacovigilance, Bayer Yakuhin Ltd, 2-4-9 Umeda, Kita-Ku, Osaka, Breeze Tower, 530-0001, Japan. suguru.okami@bayer.com.
² Aetion Inc, 5 Penn Plaza, New York, USA.
³ Medical Affairs & Pharmacovigilance, Bayer Yakuhin Ltd, 2-4-9 Umeda, Kita-Ku, Osaka, Breeze Tower, 530-0001, Japan.
⁴ Market Access & Public Affairs, Bayer Yakuhin, Ltd, 2-4-9 Umeda, Kita-Ku, Osaka, Japan.
⁵ Integrated Evidence Generation & Business Innovation, Bayer AG, 13342, Berlin, Germany.
⁶ Integrated Evidence Generation & Business Innovation, Bayer AG, 42096, Wuppertal, Germany.
⁷ Integrated Evidence Generation & Business Innovation, Bayer Consumer Care AG, Peter Merian Straße 84, 4052, Basel, Switzerland.

No abstract available

Erratum for

Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan.
Okami S, Lecomte C, Raad H, Aguila M, Mohrova Z, Takeichi M, Tsuchiya T, Ohlmeier C, Evers T, Michel A. Okami S, et al. Sci Rep. 2024 Apr 20;14(1):9095. doi: 10.1038/s41598-024-60011-y. Sci Rep. 2024. PMID: 38643208 Free PMC article.